Abstract
Although panipenem-betamipron, which is commercially available only in Japan, is recommended for treatment of pediatric bacterial meningitis by some experts, only a limited number of clinical studies have been reported. In the present report, we describe a 2-year-old boy with meningitis caused by Listeria monocytogenes who was treated with a regimen containing panipenem-betamipron and recovered without any apparent neurological sequelae. On the basis of our experience and previous reports, panipenem-betamipron appears to be effective for the treatment of listerial meningitis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hitomi, S., Ohto, T., Okamoto, M. et al. A case of listerial meningitis treated with a regimen containing panipenem-betamipron. J Infect Chemother 10, 242–244 (2004). https://doi.org/10.1007/s10156-004-0323-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10156-004-0323-5